agilon health, inc. (AGL) Stock Analysis

agilon health operates a Medicare-centric, globally capitated value-based care platform spanning 28 anchor physician groups across 30 U.S. geographies, serving approximately 511,000 Medicare Advantage members and 114,000 Medicare fee-for-service beneficiaries through nine CMS Accountable Care Organizations as of December 31, 2025. In November 2025, the company received a NYSE notice that its common stock price had fallen out of compliance with minimum listing standards, and it is pursuing a reverse stock split subject to stockholder approval to regain compliance.

agilon earns revenue primarily through per-member-per-month global capitation payments from Medicare Advantage payors, funneled through wholly owned risk-bearing entities that assume financial responsibility for members' total Part A and B medical costs and, in some contracts, Part D pharmacy costs. Anchor physician groups receive a fee-for-service base compensation rate plus a share of any surplus the RBE generates by improving quality and lowering medical costs, under professional service agreements that typically run 20 years with the base-compensation rate renegotiated after the first ten years. When agilon enters a new payor contract, the payor typically requires it to post risk-bearing capital, usually 1.0% to 3.0% of the contract's projected annual gross revenue, in the form of letters of credit, surety bonds or restricted deposits. Separately, agilon's nine CMS Accountable Care Organizations operate under the ACO REACH Model and MSSP, both of which face a structural transition: CMS has announced ACO REACH will terminate at the end of 2026 and be replaced by the untested LEAD Model beginning January 1, 2027.